U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Bremelanotide

Last Revision: October 23, 2019.

Estimated reading time: 1 minute

CASRN: 189691-06-3

image 135246805 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of bremelanotide during breastfeeding. Because bremelanotide is a cyclic peptide molecule with a molecular weight of 1025, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Until more data become available, bremelanotide should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Bremelanotide

CAS Registry Number

189691-06-3

Drug Class

Breastfeeding

Lactation

Peptides, Cyclic

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK544629PMID: 31369224

Views

Related information

Similar articles in PubMed

  • Review Liraglutide.[Drugs and Lactation Database (...]
    Review Liraglutide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Exenatide.[Drugs and Lactation Database (...]
    Review Exenatide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Eptifibatide.[Drugs and Lactation Database (...]
    Review Eptifibatide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Lixisenatide.[Drugs and Lactation Database (...]
    Review Lixisenatide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Semaglutide.[Drugs and Lactation Database (...]
    Review Semaglutide.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...